Carson Wealth (CWM LLC)’s Immunocore IMCR Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$482	Sell	16 -75	-82%	-$2.43K	﹤0.01%	5465
2025 Q4	$3K	Hold	91	–	–	﹤0.01%	4983
2025 Q3	$3K	Sell	91 -21	-19%	-$713	﹤0.01%	4902
2025 Q2	$4K	Sell	112 -56	-33%	-$1.74K	﹤0.01%	4684
2025 Q1	$5K	Sell	168 -11	-6%	-$330	﹤0.01%	4457
2024 Q4	$5K	Sell	179 -932	-84%	-$29.5K	﹤0.01%	4207
2024 Q3	$35K	Sell	1,111 -416	-27%	-$15.1K	﹤0.01%	2968
2024 Q2	$52K	Sell	1,527 -16,919	-92%	-$863K	﹤0.01%	2453
2024 Q1	$1.2M	Sell	18,446 -5,779	-24%	-$397K	0.01%	791
2023 Q4	$1.66M	Sell	24,225 -29,176	-55%	-$1.52M	0.01%	620
2023 Q3	$2.77M	Sell	53,401 -2,132	-4%	-$126K	0.02%	475
2023 Q2	$3.33M	Sell	55,533 -2,175	-4%	-$124K	0.02%	423
2023 Q1	$2.85M	Sell	57,708 -2,737	-5%	-$154K	0.02%	425
2022 Q4	$3.45M	Sell	60,445 -10,189	-14%	-$574K	0.03%	373
2022 Q3	$3.32M	Sell	70,634 -2,402	-3%	-$114K	0.03%	344
2022 Q2	$2.73M	Buy	+73,036	New	+$2.37M	0.02%	369

Other funds holding IMCR

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Carson Wealth (CWM LLC)'s IMCR Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Immunocore (IMCR) stake by 82% in Q1 2026, selling an estimated $2.43K and leaving 16 shares worth $482. The position accounts for ﹤0.01% of the portfolio, ranked #5465.

Carson Wealth (CWM LLC) first reported a position in IMCR in Q2 2022 and has held it in 16 quarters since. The position peaked at $3.45M in Q4 2022. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

Carson Wealth (CWM LLC) held 16 shares of Immunocore worth $482 as of Q1 2026.
Carson Wealth (CWM LLC) sold 75 Immunocore shares in Q1 2026, an estimated $2.43K.
Immunocore made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5465 holding.
Carson Wealth (CWM LLC) first reported a position in Immunocore in Q2 2022 and has held it in 16 quarters since.
Carson Wealth (CWM LLC)'s Immunocore position peaked at $3.45M in Q4 2022.
142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.